Madrigal Pharmaceuticals

Latest news

• Return on invested capital % of Madrigal Pharmaceuticals, Inc. – HAN:YDO1 (opens in a new tab)

  TradingView · Sep 30, 2026

• Under an automatic trading plan, director Paul Friedman proposes to sell shares in Madrigal Pharmaceuticals (MDGL). (opens in a new tab)

  Stock Titan · Sep 28, 2026

• How New Headquarters Opening At Madrigal Pharmaceuticals (MDGL) Has Changed Its Investment Story (opens in a new tab)

  Simply Wall Street · Sep 26, 2026

• MDGL Reinstated by Goldman Sachs -- Price Target Announced at $7 (opens in a new tab)

  GuruFocus · Sep 24, 2026

• Goldman Sachs assumes Madrigal Pharmaceuticals stock with buy rating (opens in a new tab)

  Investing.com India · Sep 24, 2026

• Goldman Sachs Reinitiates Coverage on Madrigal Pharmaceuticals (MDGL) with Buy Rating and $704 Price Target (opens in a new tab)

  GuruFocus · Sep 24, 2026

• People on the Move: Michael Utz Joins Madrigal Pharmaceuticals as Senior Director, Commercial Development - Marketing (opens in a new tab)

  BioBuzz · Sep 23, 2026

• Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target (opens in a new tab)

  Yahoo Finance · Sep 23, 2026

• Citi Initiates Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Announces Target Price $725 (opens in a new tab)

  Moomoo · Sep 23, 2026

• (MDGL) Volatility Zones as Tactical Triggers (opens in a new tab)

  Stock Traders Daily · Sep 22, 2026

• Madrigal Pharmaceuticals stock falls 1.80 percent as valuation stays high (opens in a new tab)

  AD HOC NEWS · Sep 22, 2026

• Madrigal Grants Equity Awards to 27 New Employees (opens in a new tab)

  MyChesCo · Sep 21, 2026

• Madrigal Pharmaceuticals stock trades around 531 dollars as institutional interest stays strong (opens in a new tab)

  AD HOC NEWS · Sep 21, 2026

• Madrigal Pharmaceuticals stock holds above 530 dollars after recent ownership change (opens in a new tab)

  AD HOC NEWS · Sep 20, 2026

• Can Madrigal Pharmaceuticals (MDGL) Be A Bargain As It Opens Its New Headquarters? (opens in a new tab)

  Simply Wall Street · Sep 19, 2026

• How New Headquarters At Madrigal Pharmaceuticals Stock Has Changed Its Investment Story (opens in a new tab)

  Simply Wall Street · Sep 18, 2026

• Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) (opens in a new tab)

  Yahoo Finance · Sep 16, 2026

• Shapiro Administration Highlights Importance of New Innovate in PA 2.0 Program During Opening of Madrigal Pharmaceuticals’ Headquarters in Montgomery County (opens in a new tab)

  PA Department of Community & Economic Development (.gov) · Sep 14, 2026

• Madrigal unveils new HQ with sales of flagship drug on pace to top $1B this year (opens in a new tab)

  The Business Journals · Sep 14, 2026

• Madrigal Pharmaceuticals (NASDAQ: MDGL) insider plans another stock sale after recent multimillion-dollar trades (opens in a new tab)

  Stock Titan · Sep 11, 2026

• Madrigal at cantor healthcare conference: growth, access and pipeline By Investing.com (opens in a new tab)

  Investing.com UK · Sep 10, 2026

• Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You? (opens in a new tab)

  fool.com · Sep 10, 2026

• Madrigal Pharmaceuticals (NASDAQ: MDGL) exec plans $3.4M stock sale for tax withholding (opens in a new tab)

  Stock Titan · Sep 9, 2026